AzurRx BioPharma

$1.16
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.14 (-11.11%) As of 7:30 PM UTC today

Why Robinhood?

You can buy or sell AZRX and other stocks, options, and ETFs commission-free!

About AZRX

AzurRx BioPharma, Inc. engages in the research and development of non-systemic biologics for the treatment of patients with gastrointestinal disorders. It focuses on MS1819-SD, and B-Lactamase program products. The company was founded on January 30, 2014 and is headquartered in Delray Beach, FL. The listed name for AZRX is AzurRx BioPharma, Inc. Common Stock.

CEO
James E. Sapirstein
Employees
10
Headquarters
Delray Beach, Florida
Founded
2014
Market Cap
64.20M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
2.13M
High Today
$1.29
Low Today
$1.13
Open Price
$1.25
Volume
2.33M
52 Week High
$2.63
52 Week Low
$0.3709

AZRX Earnings

-$0.46
-$0.31
-$0.15
$0.00
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Mar 29, After Hours

You May Also Like

EFR
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure